- Home
- INKT vs BRLT Comparison
INKT vs BRLT Comparison
Compare INKT & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INKT | BRLT |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.4M | 18.9M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INKT | BRLT |
|---|---|---|
| Price | $11.54 | $1.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $35.00 | $1.70 |
| AVG Volume (30 Days) | 12.3K | ★ 109.6K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $437,483,000.00 |
| Revenue This Year | N/A | $6.72 |
| Revenue Next Year | N/A | $4.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.63 |
| 52 Week Low | $8.48 | $1.00 |
| 52 Week High | $16.80 | $2.90 |
Technical Indicators
Market Signals| Indicator | INKT | BRLT |
|---|---|---|
| Relative Strength Index (RSI) | 48.80 | 56.01 |
| Support Level | $10.79 | $1.24 |
| Resistance Level | $12.04 | $1.41 |
| Average True Range (ATR) | 0.52 | 0.09 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 31.55 | 57.69 |
Price Performance
Historical ComparisonAbout INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is an digitally native omnichannel jewelry company selling The company's products include rings, necklaces, earrings, and bracelets. Its collection of premium-quality diamond engagement and wedding rings, gemstone rings, and fine jewelry is conceptualized by in-house design studio. The company operates in one operating and reporting segment, the retail sale of diamonds, gemstones and jewelry.